LIPOCINE INC. Deferred Tax Assets, Operating Loss Carryforwards
LIPOCINE INC. (LPCN) had Deferred Tax Assets, Operating Loss Carryforwards of $78.20 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-10
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $78.20M.
- 2013-06-30: Deferred Tax Assets, Operating Loss Carryforwards $13.22K.
- 2013-03-31: Deferred Tax Assets, Operating Loss Carryforwards $12.75K.
- 2012-12-31: Deferred Tax Assets, Operating Loss Carryforwards $12.27K.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $78.20M 10-K · filed 2026-03-10 |
| 2013-06-30 | $13.22K 10-Q · filed 2013-07-09 |
| 2013-03-31 | $12.75K 10-Q · filed 2013-04-24 |
| 2012-12-31 | $12.27K 10-Q · filed 2013-07-09 |
| 2011-12-31 | $774.00 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |